Global Real World Evidence Solutions Market to Reach US$1.9 Billion by the Year 2027
31 déc. 2020 06h38 HE
|
Research and Markets
Dublin, Dec. 31, 2020 (GLOBE NEWSWIRE) -- The "Real World Evidence Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the...
Global Actinic (Solar) Keratosis Clinical Trials Review, H2, 2020 - 10 Companies Involved
23 déc. 2020 03h53 HE
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Actinic (Solar) Keratosis Global Clinical Trials Review, H2, 2020" clinical trials has been added to ResearchAndMarkets.com's offering. "Actinic...
FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals’ Brilacidin for Treating COVID-19
21 déc. 2020 07h00 HE
|
Innovation Pharmaceuticals Inc.
Brilacidin’s potent in vitro inhibition of the Washington and Italian strains of SARS-CoV-2 support its potential to inhibit emerging coronavirus mutations (variants), such as those in the United...
PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities
17 déc. 2020 16h02 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Dec. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing...
Ivy Brain Tumor Center Initiates Phase 0 Clinical Trial with BeiGene for Newly Diagnosed and Recurrent Glioblastoma
16 déc. 2020 07h00 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute today announced the opening of a Phase 0 clinical trial for patients with newly diagnosed...
Phathom Pharmaceuticals Announces Plans to Initiate Vonoprazan Development Program in Non-Erosive Reflux Disease (NERD)
14 déc. 2020 08h30 HE
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
Neoleukin Therapeutics Announces Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer
10 déc. 2020 08h00 HE
|
Neoleukin Therapeutics, Inc.
SEATTLE, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de...
Worldwide Insights on the Bevacizumab Biosimilar Industry to 2025 - Featuring Amgen, AryoGen Pharmed and Biothera Among Others
10 déc. 2020 05h43 HE
|
Research and Markets
Dublin, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The "Bevacizumab Biosimilar Market Opportunity, Sales, Price & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's offering....
Outlook on the Trispecific Antibodies Global Market to 2024 - Featuring AbbVie, Affimed and Biotheus Among Others
10 déc. 2020 05h23 HE
|
Research and Markets
Dublin, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The "Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
Ehave Dashboard Enters Final Simulations of Clinical Trials with the Hospital for Sick Children
04 déc. 2020 09h00 HE
|
Ehave
The Ehave Dashboard has the ability to segment data on-chain, which will allow developers, clinicians, researchers, doctors, hospitals, and universities to provide life-changing solutions to patients....